Authors
Starting from RuHCl(H2)(PCy3)2, a terminal ruthenium mesitylborylene complex was obtained via double B-H bond activation of mesitylborane and concomitant release of dihydrogen, such a process being remarkably reversible.
No takes yet. Share an insight, caveat, or question.
Alcaraz et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: